Clinical Trial

Natural History and Prognosis of Pediatric Epilepsies With Different Etiology

Recruiting
View on ClinicalTrials.gov →
Summary
Epilepsy is one of the most common neurological diseases in Italy, affecting about 500,000 people. Pediatric age represents one of the most affected groups with a consequent significant impact on the quality of life of the families involved. The study aims to monitor the cognitive functions of patients followed at our center in order to determine the main types of pathways and highlight their determinants. The ultimate goal is to define what are the main clinical and instrumental predictors of cognitive function and its variation over time.
Trial Details
NCT Number NCT07588971
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Pediatric Epilepsies
Enrollment 2,300 participants
Start Date 2021-10-26
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-15